INVA
INVA
NASDAQ · Pharmaceuticals

Innoviva Inc

$24.08
+0.53 (+2.25%)
Day Range $23.61 — $24.09
52W Range $16.52 — $25.15
Open$23.66
Previous Close$23.55
Day High$24.09
Day Low$23.61
52W High$25.15
52W Low$16.52
Volume
Avg Volume781.2K
Market Cap1.66B
P/E Ratio3.29
EPS$5.94
SectorPharmaceuticals

Analyst Ratings

Strong Buy
11 analysts
9 Buy 1 Hold 1 Sell
Price Target +62.6% upside
Current
$24.08
Target
$39.16
$23.99 $39.16 avg $41.33

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 358.82M 333.85M 296.49M
Net Income 236.55M 198.08M 100.45M
Profit Margin 65.9% 62.6% 33.9%
EBITDA 155.02M 137.02M 161.71M
Free Cash Flow 84.32M
Rev Growth +7.5% +7.5% +12.4%
Debt/Equity 0.22 0.22 0.49

Pharmaceuticals Peers

Symbol Name Price Change P/E Mkt Cap
LLY Eli Lilly and Co. $1,107.08 +0.45% 40.9 1.03T
JNJ Johnson & Johnson $239.08 +3.37% 26.1 549.78B
MRK Merck & Co. Inc. $119.60 +3.57% 31.5 281.24B
PFE Pfizer Inc. $24.72 -1.44% 19.2 143.68B
BMY Bristol-Myers Squibb Co $55.53 +1.52% 18.5 110.27B
ZTS Zoetis Inc $76.84 +1.25% 12.5 33.00B

INVA News

No news for INVA yet

Quick Stats

Market Cap1.66B
P/E Ratio3.29
EPS$5.94
Volume
SectorPharmaceuticals